Bally’s Corporation (NYSE: BALY) eyes evoke plc (LSE: EVOK): why a William Hill deal would reshape UK gambling
Read More Pharma Industry News Why Shilpa’s bet on Alveolus Bio may reshape the future of pulmonary biologics Shilpa Medicare leads funding round in Alveolus Bio to accelerate Phase 2 COPD trials and first-in-human studies for novel inhaled therapeutics. byPallavi MadhirajuAugust 4, 2025